Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3',4'-anhydroadenosylcobalamin
2. 5'-deoxyadenosylcobalamin
3. Adenosylcobalamin
4. Adocbl
5. Cobamamide
6. Desoxyadenosylcobalamine
7. Dibencozide
8. Indusil T
9. Vitamin B12 Coenzyme
1. Cobamamide
2. 13870-90-1
3. Calomide
4. Cobalamine Coenzyme
5. Vitamin B12 Coenzyme
6. 5-deoxyadenosylcobalamin
7. 5'-deoxyadenosylcobalamine
8. Mfcd00135609
9. Akos025311252
Molecular Weight | 1579.6 g/mol |
---|---|
Molecular Formula | C72H100CoN18O17P |
Hydrogen Bond Donor Count | 12 |
Hydrogen Bond Acceptor Count | 27 |
Rotatable Bond Count | 27 |
Exact Mass | 1578.658339 g/mol |
Monoisotopic Mass | 1578.658339 g/mol |
Topological Polar Surface Area | 571 Ų |
Heavy Atom Count | 109 |
Formal Charge | 0 |
Complexity | 3730 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 18 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 3 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
B - Blood and blood forming organs
B03 - Antianemic preparations
B03B - Vitamin b12 and folic acid
B03BA - Vitamin b12 (cyanocobalamin and analogues)
B03BA04 - Cobamamide
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
52
PharmaCompass offers a list of Cobamamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cobamamide manufacturer or Cobamamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cobamamide manufacturer or Cobamamide supplier.
PharmaCompass also assists you with knowing the Cobamamide API Price utilized in the formulation of products. Cobamamide API Price is not always fixed or binding as the Cobamamide Price is obtained through a variety of data sources. The Cobamamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A dibencozide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of dibencozide, including repackagers and relabelers. The FDA regulates dibencozide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. dibencozide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of dibencozide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A dibencozide supplier is an individual or a company that provides dibencozide active pharmaceutical ingredient (API) or dibencozide finished formulations upon request. The dibencozide suppliers may include dibencozide API manufacturers, exporters, distributors and traders.
click here to find a list of dibencozide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A dibencozide DMF (Drug Master File) is a document detailing the whole manufacturing process of dibencozide active pharmaceutical ingredient (API) in detail. Different forms of dibencozide DMFs exist exist since differing nations have different regulations, such as dibencozide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A dibencozide DMF submitted to regulatory agencies in the US is known as a USDMF. dibencozide USDMF includes data on dibencozide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The dibencozide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of dibencozide suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The dibencozide Drug Master File in Japan (dibencozide JDMF) empowers dibencozide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the dibencozide JDMF during the approval evaluation for pharmaceutical products. At the time of dibencozide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of dibencozide suppliers with JDMF on PharmaCompass.
dibencozide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of dibencozide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right dibencozide GMP manufacturer or dibencozide GMP API supplier for your needs.
A dibencozide CoA (Certificate of Analysis) is a formal document that attests to dibencozide's compliance with dibencozide specifications and serves as a tool for batch-level quality control.
dibencozide CoA mostly includes findings from lab analyses of a specific batch. For each dibencozide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
dibencozide may be tested according to a variety of international standards, such as European Pharmacopoeia (dibencozide EP), dibencozide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (dibencozide USP).